Jain Global’s SELLAS Life Sciences SLS Stock Holding History

Jain Global’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,400	Closed	-$29.6K	–	1581
2025 Q1	$29.6K	Buy	+27,400	New	+$32.5K	﹤0.01%	1030

Other funds holding SLS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jain Global's SLS Position: Q2 2025 in Review

Jain Global sold out of SELLAS Life Sciences (SLS) in Q2 2025, closing a stake of 27,400 shares — an estimated $29.6K sold.

Jain Global first reported a position in SLS in Q1 2025 and held it in 1 quarter. The position peaked at $29.6K in Q1 2025. 79 funds tracked by Wall St. Rank hold SLS as of Q2 2025.

Jain Global reported no remaining SELLAS Life Sciences position as of Q2 2025 after selling out during the quarter.
Jain Global sold 27,400 SELLAS Life Sciences shares in Q2 2025, an estimated $29.6K.
Jain Global first reported a position in SELLAS Life Sciences in Q1 2025 and held it in 1 quarter.
Jain Global's SELLAS Life Sciences position peaked at $29.6K in Q1 2025.
79 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.